Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late‐Preterm Twin Infants
Pediatric Pulmonology · 2026-08 · 61 (8)
DOI: 10.1002/ppul.71755 ↗At a glance
Journal article in Pediatric Pulmonology, published online on 2026-07-27. Written by Satoshi Shinohara and 6 co-authors. Institution: Department of Obstetrics and Gynecology, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, Japan. Major MEDLINE topics: Magnesium Sulfate, Apnea, Infant, Premature, Diseases, Tocolytic Agents. 24 references. The full text is freely available in PubMed Central.
Abstract (original language)
Objective
To evaluate the association between the timing of maternal magnesium sulfate (MgSO 4 ) discontinuation before delivery and the risk of apnea of prematurity (AOP) in late‐preterm twin infants.
Methods
This retrospective cohort study included 161 twin pregnancies (322 infants) delivered between 34 0/7 and 36 6/7 weeks at Yamanashi Prefectural Central Hospital (2017–2025). Infants with major anomalies or intrauterine fetal demise were excluded. The primary exposure was the interval between MgSO 4 cessation and delivery, categorized as: no exposure, < 12, 12–24, and ≥ 24 h. Two multivariable logistic regression models were constructed. Model 1 evaluated the association between any maternal MgSO 4 exposure and AOP. Model 2 further incorporated the timing of MgSO 4 discontinuation as a categorical exposure, adjusting for gestational age, chorionicity, small‐for‐gestational‐age status, sex, and 1‐min Apgar score.
Results
Among the 322 infants, 112 (34.8%) developed AOP. In Model 1, maternal MgSO 4 exposure itself was not significantly associated with AOP. However, in Model 2, delivery within 12 h after cessation of MgSO 4 was independently associated with AOP (adjusted odds ratio, 7.44; 95% confidence interval, 1.48–37.4), whereas longer discontinuation intervals (12–24 or ≥ 24 h) were not.
Conclusions
Among late‐preterm twin infants, maternal MgSO 4 exposure itself was not independently associated with AOP; however, delivery soon after MgSO 4 discontinuation was associated with an increased risk of AOP. These findings support consideration of MgSO 4 discontinuation timing in perinatal risk assessment and neonatal respiratory monitoring and may help guide future studies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Obstetrics and Gynecology, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, Japan.
- Department of Neonatology, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, Japan.
Cite
APA
Shinohara, S., Yasuda, G., Kasai, M., Katsumata, N., Nemoto, A., Naito, A., & Sunami, R. (2026). Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late‐Preterm Twin Infants. Pediatric Pulmonology, 61(8). https://doi.org/10.1002/ppul.71755
Vancouver
Shinohara S, Yasuda G, Kasai M, Katsumata N, Nemoto A, Naito A, et al. Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late‐Preterm Twin Infants. Pediatric Pulmonology. 2026;61(8). doi:10.1002/ppul.71755
BibTeX
@article{Shinohara2026,
author = {Shinohara, Satoshi and Yasuda, Genki and Kasai, Mayuko and Katsumata, Nobuyuki and Nemoto, Atsushi and Naito, Atsushi and Sunami, Rei},
title = {Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late‐Preterm Twin Infants},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {8},
doi = {10.1002/ppul.71755}
}
EUVIMED